State of Wisconsin Investment Board’s Myriad Genetics MYGN Stock Holding History

State of Wisconsin Investment Board’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.81M	Buy	402,518 +114,901	+40%	+$599K	﹤0.01%	1437
2025 Q4	$1.77M	Sell	287,617 -11,217	-4%	-$81.3K	﹤0.01%	1462
2025 Q3	$2.16M	Sell	298,834 -238,611	-44%	-$1.42M	0.01%	1327
2025 Q2	$2.85M	Buy	537,445 +312,206	+139%	+$1.84M	0.01%	1138
2025 Q1	$2M	Buy	225,239 +81,907	+57%	+$984K	0.01%	1243
2024 Q4	$1.97M	Buy	143,332 +21,988	+18%	+$406K	0.01%	1291
2024 Q3	$3.32M	Sell	121,344 -15,479	-11%	-$419K	0.01%	1120
2024 Q2	$3.35M	Sell	136,823 -1,086	-0.8%	-$23.8K	0.01%	1091
2024 Q1	$2.94M	Buy	137,909 +8,003	+6%	+$172K	0.01%	1133
2023 Q4	$2.49M	Buy	129,906 +59,732	+85%	+$1.03M	0.01%	1191
2023 Q3	$1.13M	Sell	70,174 -799	-1%	-$15.2K	﹤0.01%	1366
2023 Q2	$1.65M	Sell	70,973 -5,161	-7%	-$113K	﹤0.01%	1347
2023 Q1	$1.77M	Sell	76,134 -2,319	-3%	-$47.1K	0.01%	1338
2022 Q4	$1.14M	Sell	78,453 -2,722	-3%	-$50.7K	﹤0.01%	1447
2022 Q3	$1.55M	Sell	81,175 -5,299	-6%	-$122K	﹤0.01%	1405
2022 Q2	$1.57M	Sell	86,474 -19,726	-19%	-$410K	﹤0.01%	1434
2022 Q1	$2.68M	Sell	106,200 -1,500	-1%	-$38.4K	0.01%	1406
2021 Q4	$2.97M	Buy	107,700 +2,100	+2%	+$60.8K	0.01%	1174
2021 Q3	$3.41M	Buy	105,600 +9,800	+10%	+$325K	0.01%	1155
2021 Q2	$2.93M	Hold	95,800	–	–	0.01%	1194
2021 Q1	$2.92M	Sell	95,800 -2,200	-2%	-$62.4K	0.01%	1162
2020 Q4	$1.94M	Sell	98,000 -12,200	-11%	-$197K	﹤0.01%	1211
2020 Q3	$1.44M	Hold	110,200	–	–	﹤0.01%	1219
2020 Q2	$1.25M	Buy	110,200 +500	+0.5%	+$7.1K	﹤0.01%	1202
2020 Q1	$1.57M	Buy	109,700 +4,700	+4%	+$99.3K	0.01%	1116
2019 Q4	$2.86M	Hold	105,000	–	–	0.01%	1073
2019 Q3	$3.01M	Buy	105,000 +6,700	+7%	+$195K	0.01%	941
2019 Q2	$2.73M	Buy	98,300 +2,200	+2%	+$62.1K	0.01%	964
2019 Q1	$3.19M	Buy	96,100 +27,800	+41%	+$846K	0.01%	909
2018 Q4	$1.99M	Buy	68,300 +1,500	+2%	+$54K	0.01%	976
2018 Q3	$3.07M	Hold	66,800	–	–	0.01%	967
2018 Q2	$2.5M	Buy	66,800 +3,000	+5%	+$101K	0.01%	963
2018 Q1	$1.89M	Hold	63,800	–	–	0.01%	980
2017 Q4	$2.19M	Buy	63,800 +17,800	+39%	+$601K	0.01%	966
2017 Q3	$1.66M	Hold	46,000	–	–	﹤0.01%	985
2017 Q2	$1.19M	Buy	+46,000	New	+$977K	﹤0.01%	1032
2015 Q2	–	Sell	-56,811	Closed	-$2.01M	–	1361
2015 Q1	$2.01M	Sell	56,811 -1,560	-3%	-$55.8K	0.01%	1162
2014 Q4	$1.99M	Buy	58,371 +3,330	+6%	+$118K	0.01%	1168
2014 Q3	$2.12M	Buy	55,041 +400	+0.7%	+$14.9K	0.01%	1143
2014 Q2	$2.13M	Buy	54,641 +1,220	+2%	+$45.4K	0.01%	1159
2014 Q1	$1.83M	Buy	53,421 +120	+0.2%	+$3.72K	0.01%	1170
2013 Q4	$1.12M	Buy	+53,301	New	+$1.35M	﹤0.01%	1230

Other funds holding MYGN

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State of Wisconsin Investment Board's MYGN Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Myriad Genetics (MYGN) stake by 40% in Q1 2026, buying an estimated $599K and bringing the position to 402,518 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1437.

State of Wisconsin Investment Board first reported a position in MYGN in Q4 2013 and has held it in 42 quarters since. The position peaked at $3.41M in Q3 2021. 202 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.

State of Wisconsin Investment Board held 402,518 shares of Myriad Genetics worth $1.81M as of Q1 2026.
State of Wisconsin Investment Board bought 114,901 Myriad Genetics shares in Q1 2026, an estimated $599K.
Myriad Genetics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1437 holding.
State of Wisconsin Investment Board first reported a position in Myriad Genetics in Q4 2013 and has held it in 42 quarters since.
State of Wisconsin Investment Board's Myriad Genetics position peaked at $3.41M in Q3 2021.
202 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.